In this paper, we present low-power circuit techniques for implementing a closed-loop neurostimulator (CLNS) as an alternative treatment for medically refractory epilepsy. The proposed circuit has low-power dissipation with better detection sensitivity compared to the recently proposed circuit techniques for epileptic seizure detector. We demonstrate low-power circuit techniques for implementation of an implantable CLNS, individual functional testing, and validation of the seizure detector on real intracerebral EEG (icEEG) recordings and testing of self-triggering electrical stimulation. The CLNS comprises a low-power icEEG acquisition front-end, epileptic seizure detector, and a widely programmable current stimulator. Moreover, the tuneable parameters of the detector and stimulator are designed to adjust wirelessly. The detection algorithm was validated with Matlab tools and the detection circuits were implemented in 2 mm 2 chip area using CMOS 0.18-m process. The current-mode stimulator was assembled on two circular (Ø 20 mm) shape blocks in a printed circuit board (PCB). The proposed CLNS was tested using icEEG recordings from seven patients with medically refractory epilepsy. The icEEG recordings were assessed by the proposed CLNS and the predefined seizure suppression biphasic electrical stimulations were triggered ∼14.4 s after electrographical seizure onsets.
INTRODUCTION
The growing demand for low power dissipation has been driven by implantable battery-powered therapeutic systems that demand ever-increasing functionality and battery life. The implantable medical devices have been widely used to restore neurological disorders including Parkinson's disease, epilepsy, urinary bladder dysfunctions, and restoration of vision. Epilepsy is the second most common neurological disorder, affecting ∼50 million people worldwide. Antiepileptic drugs are the mainstay of epilepsy treatment. Though close to two-thirds of patients are controlled by oral medications, many report side effects and the rest continue to suffer from disabling seizures. 1 2 Epilepsy surgery may be an option in the presence of a well delineated epileptogenic zone (EZ) located in an area that can be resected without harm. 1 3 4 For those with a poorly defined epileptic focus, multifocal epilepsy, an EZ located in a highly functional/non-resectable area or those with persisting seizures despite attempted resective surgery, additional therapeutic options are needed.
Proof-of-concept experiments conducted in animals and humans have demonstrated the safety of successful chronic electrical stimulation for the treatment of epilepsy. [5] [6] [7] At first, the Vagus nerve stimulator was introduced for adjunctive treatment of patients with partial seizures with or without secondary generalization or generalized seizures that are refractory to antiepileptic medications (approved in 1997 by FDA). 8 9 Efficacy of this scheduled (open-loop) stimulation device is, however, limited to a 3% rate of seizure-freedom and a 30-40% responder rate (i.e., showing more than 50% reduction in seizure frequency). [8] [9] [10] A more recent approach has been to look at closedloop stimulation triggered upon detection of an electrographic seizure onset. 8 9 The RNS system (Neuropace Inc.) is a cranially implanted responsive neurostimulator designed to detect seizure activity in the brain and to deliver predefined electrical stimulation to suppress seizures before any seizure symptoms appear. 6 A recent pivotal randomized double-blind sham stimulation controlled trial assessing the efficacy and safety of the RNS system showed moderate reduction in seizure frequency in patients with refractory partial onset epilepsy originating from one or two locations in the brain. 6 Closed-loop stimulation 5 6 11 12 has some potential advantages over the open-loop method: 8-10 13 (i) lower number of treatments; (ii) fewer stimulation-related adverse events, (iii) high efficiency due to rapid access; and (iv) ability to review recordings to monitor seizure frequency.
Any closed-loop system relies upon accurate seizure onset detection (without false alarms).
In the last decade, many mathematical models have been developed for seizure detection based on wavelet, 14 entropy-based approach, 15 spectral feature extraction, 16 and spectral instability. 17 These models were developed using desktop computers for off-time data processing and cannot be employed in a low-power implantable microchip due to the heavy computation. However, several seizure detection algorithms have been proposed for low-power implantable device and hardware implementations have been shown feasible using CMOS 0.18-m, [18] [19] [20] [21] [22] [23] MIT 180 nm SOI, [24] [25] TSMC 65 nm 26 and CMOS 0.13-m 27 process. These types of implementation in custom integrated circuits are sensitive enough to detect seizures early on but also specific enough to prevent unwarrantedly triggered focal intervention. Therefore, the seizure detectors need complicated functionalities which result in higher power consumption. Power management is an important issue for medical devices. Although rechargeable wireless batteries may partially solve the problem, it is important to improve the implantable devices with new features/system design to minimize power dissipation while optimizing their performance. Apart from the seizure detection performance, the other concerns are safety of chronic electrical stimulation and the determination of optimal stimulation parameters. Table  I shows the parameters used in pilot trials. Osorio et al. demonstrated the feasibility and short-term safety of automated high-frequency electrical stimulation (100-500 Hz) in blocking seizures using an external prototype. 11 Moreover, many promising advances have been made in the [28] [29] [30] and restoration of vision. [31] [32] [33] However, several issues remain to be addressed for the electrical brain stimulation treatment for epilepsy, such as maximum charge density, stimulation mode, current distribution, shunting of injected current, impedance of cerebral tissue, and the region affected by stimulation.
In this paper, we present low-power circuit techniques for implementing responsive neurostimulator for the treatment of refractory partial onset epilepsy. This prosthetic device analyzes the intracerebral EEG (icEEG) recording, detects electrographic seizures at their onset, and triggers focal electrical stimulation to the EZ (or a chosen target such as the anterior thalamic nucleus) to abort the seizure. The device comprises intracranial electrode contacts, the icEEG acquisition front-end, a seizure detector, and an electrical stimulator. The proposed seizure detection algorithm has enhanced sensitivity of detection for the patient-specific seizure pattern, while minimize power dissipation. Moreover, the algorithm reduces instrumentational low-frequency noises by manipulating the icEEG recording into high frequency and demodulating the signal to the original frequency band in the digital domain. The widely programmable electrical stimulator is suitable for the treatment of refractory epilepsy. The performance of the proposed CLNS is verified using icEEG recordings from seven patients with refractory partial epilepsy. The measured results of CLNS demonstrate the reliability of the system in an implantable device for neurostimulation therapies.
METHOD OF TREATMENT
The proposed CLNS is designed to deliver high frequency electrical stimulation (100-500 Hz) directly to the EZ at seizure onset prior to clinical manifestation. The CLNS is dedicated to the treatment of refractory partial epilepsy. The CLNS will be implanted within the skull and interfaced directly with the recording/stimulation sites ( Fig. 1(a) ). The CLNS comprises subdural or depth electrodes, a seizure detector (SD) and an electrical stimulator (ES). Figure 1(b) illustrates the functional block diagram and flowchart of the CLNS. The corresponding graphic representation in Figure 1 (c) demonstrates the real-time icEEG recording (V in acquisition, seizure detection (V SOD at their onset, and triggering of direct electrical stimulation (I STIM for T 1 period to the EZ to abort the seizure, while another seizure detection begins after T 2 , if the seizure does not terminate. The SD and ES have different tuneable parameters designed to detect patient-specific seizure onset patterns and provide individualized effective bipolar biphasic stimulation to the brain tissue in order to disrupt seizures. The SD requires low-power, continuous, long-term icEEG monitoring to identify seizures online before the appearance of disabling clinical manifestations (e.g., altered consciousness, tonic or clonic movements). On the other hand, ES remains in sleep mode, unless SD triggers it to active (stimulation) mode.
After the implant procedure, patients need to have follow-up visits with the clinician to program the CLNS. The clinician uses external controller to program the CLNS. This programming session sets the optimal detection and stimulation parameters to best manage patient's seizures while minimizing side effects. Battery life of CLNS can vary depending upon the programmed stimulation parameters (e.g., amplitude, frequency, pulse width) and number of seizure detection. However, this battery can be recharged wirelessly through the skin; moreover, it will be automatically recharged during the programming session. The frequency of these follow-ups depends on the medical background of the patients and the individual circumstances.
Low-Power Accurate Seizure Detector Design
The proposed seizure detector performs real-time icEEG analysis, of which output triggers a burst of electrical stimulation. This epileptic seizure detector is designed for lower power dissipation and instrumentational lowfrequency noises isolation (e.g., flicker noise, dc offset voltage, and thermal noise) and also other sources of noise (e.g., 60 Hz noise). Mathematical model of the proposed seizure detector was introduced in our previous work 18 and here, we present a brief description of the model, and advantages and drawbacks of the model in real-time neurostimulation applications.
In this mathematical model, high sampling frequency modulates the input signal amplitude and passes through amplitude detectors with different threshold voltages to detect the specific features characterized by progressive amplitude increase. The detected amplitudes confined in a time frame pass through frequency analyzers for timefrequency analysis. Therefore, the algorithm determines the high frequency as well as progressive increases in amplitude and declares an upcoming seizure.
The input icEEG is modulated into high frequency (F s for two reasons: (i) instrumentation low-frequency noise does not affect the seizure detection performance and (ii) the amplitude modulation converts negative signal amplitudes to positive amplitudes, thus, amplitude detectors are required only in positive comparators for timeamplitude analysis.
Signal processing and demodulation are done in digital domain to reduce power dissipation and avoid addition ripple noise generated from a classical chopper preamplifier. 34 Finally, an upcoming seizure is declared without influence of internal and external noises, if the filters and detection settings are adjusted correctly; otherwise high frequency sampling noise degrades the detection performance.
Apart from the noise effects in the seizure detection, there are others biological impacts that may degrade seizure detection performance. Clinically, seizures may be electrical (especially if they occur in non-eloquent cortex and remain very focal) or electroclinical (when the ictal discharge involves/propagates to a symptomatic zone). Seizure symptoms are obviously dependent on what area of the brain is involved and may range from subtle sensations to overt convulsions. Electrographically, there are several seizure onset patterns which can be seen in icEEG recording, such as low-voltage fast-activity, high-voltage fast-activity or rhythmic spiking. 4 The proposed algorithm is designed to detect electroclinical seizures starting with low-voltage fast-activity, the most frequently encountered ictal pattern.
The ictal discharges generally contain high frequency components; however, not all high frequency discharges are seizures, as some are physiological rhythms. Therefore, the high frequency filtering from icEEG is not a sufficient criterion for detecting an epileptic seizure onset. Thus, the proposed detection algorithm incorporates both timefrequency and time-amplitude analysis of icEEG recordings. Figures 2(a)-(c) show time-frequency F SZ and timeamplitude V MA (mean absolute) analysis of different icEEG recordings of a patient to demonstrate the seizure detection criteria.
The signal analysis of normal icEEG recordings V in shows no abnormalities in F SZ and V MA (Fig. 2(a) ). A brief electrical seizure (BES) in V in (Fig. 2(b) ) has high frequency contents in F SZ , but it does not have progressive amplitude increase in V MA and stay for a short period (e.g., 4/5 s). However, the signal analysis of V in at seizure onset ( Fig. 2(c) ) demonstrates a sudden increase in F SZ and progressive amplitude increase in V MA (Fig. 2(c) ) leading to clinical manifestations. Therefore, the seizure detector proposes two detection criteria: patient-specific high frequency activity and progressive amplitude increase. Because the initial ictal electrical pattern may vary from patient to patient according to the underlying substrate, the type of intracerebral electrodes used, and their locations with respect to the EZ, the seizure detector has several adjustable parameters for optimizing sensitivity and specificity. Further details of the parameters are described in Section 3.
Stimulation Parameters
Chronic cortical electrical stimulation for the treatment of neurological conditions has been shown to be feasible, safe, tolerable and efficacious in humans. [5] [6] [7] There are two modes for the electrical stimulation: bipolar and unipolar stimulation. The unipolar mode tends to stimulate a wider region while the bipolar mode is effective in producing localized current flows. 35 Moreover, electrodetissue impedance varies over the time and a voltage controlled stimulator cannot stimulate the brain tissue with a fix current. Therefore, current controlled stimulation is always preferable because of Ohm's law and safety purpose. The current stimulator can deliver the desired quantity of charges into the brain tissue by keeping the current amplitude constant. Moreover, charge-balanced asymmetric current biphasic stimulation ( Fig. 3(a) ) can avoid damaging electrochemical processes of the brain because the anodic pulse (I STIM1 of the biphasic stimulation ( Fig. 3(a) ) activates the neurons and the cathodic pulse (I STIM2 = I STIM1 /4) removes the delivered charges of I STIM1 . However, two subsequent opposite pulses could prevent the generation of an action potential. Thus, a short time delay (T 4 between the pulses is required to propagate the action potential away from the stimulation site before removing the injected charge. It is generally agreed that limiting the maximum charge density ( MAX to 60 C/cm 2 per phase can avoid tissue damage.
6 Figure 3 (b) illustrates the electrical brain stimulation safe region using standard subdural electrodes (diameter: 5 mm and interelectrode spacing: 10 mm). The safety region is defined by Eq. (1).
where T 4 is pulse width, A is area of the electrode and I STIM is injected current to brain tissue. During the biphasic stimulation using bipolar subdural electrodes, there is significant shunting of current through the cerebrospinal fluid (CSF) because of higher (approximately four times) current density in CSF than the gray matter. 35 Therefore, the proposed CLNS has a wide range of output current I STIM .
The proper stimulation parameters need to be individualized during the presurgical icEEG study for maximum efficacy prior to the implantation of a stimulation device. The stimulation is delivered at close proximity to the seizure onset, directly to (i) EZ by subdural electrodes, which is suitable for patients with one or two discrete EZ; 6 11 or (ii) the anterior thalamic nucleus (ATN) by way of depth electrodes, which may be suitable for patients with large or more than two EZ. 13 Further details are described below. Figure 4 illustrates the architecture of the CLNS. The proposed CLNS features advance icEEG monitoring and neurostimulation technology. We achieve low-power design goal in the closed-loop system by using power gating strategy. In the CLNS, SD provides continuous long-term monitoring of icEEG and ES delivers electrical stimulation in response to seizure detection. Thus, long-term energy dissipation in CLNS is dominated by SD. The field programmable gate array (FPGA) embedded ES stays in sleep mode and shuts down output stage, unless SD triggers it to active mode. The SD comprises two main blocks: detection core and controller, and ES contains control unit and output stage. Details of the CLNS are described below. 
LOW POWER SYSTEM DESIGN METHODOLOGY

Seizure Detector
A new seizure detector chip was introduced and measurements of the chip have been reported in our previous work. 23 However, in this paper, the detector chip was integrated in a closed-loop system that monitor continuous long-term icEEG recording, adjust detection and stimulation parameters wirelessly, and able to trigger electrical stimulation on seizure detection. The detection core is responsible for icEEG acquisition front-end and epileptic seizure detection, while the controller adjusts tuneable parameters of the detection core in order to optimize the sensitivity of detection (Fig. 4) . As mentioned before, the epileptic seizure detection criteria may vary from patient to patient and detection criteria for a patient may change from time to time. Thus, the controller is introduced in SD so that a clinician can always modify the criteria through wireless communication.
Low-Power Detection Core Design
The classical chopper preamplifier 34 is widely used for icEEG acquisition front-end. Figure 5 (a) illustrates schematic diagram of a traditional detection core based on the classic preamplifier. The traditional system consumed 24.06 W. To improve power management technique, a new chopper preamplification method was integrated with the detection system ( Fig. 2(b) ). The demodulator and lowpass filter of a classical chopper preamplifier ( Fig. 2(a) ) were replaced by a rectifier and a digital demodulator (Fig. 2(b) ) to reduce addition noise (e.g., ripple noise) by demodulator and extra power consumption by a low-pass filter with sharp cutoff frequency. Moreover, the traditional design required four amplitude detectors (ADs) (positive and negative comparators) and four frequency detectors (FDs) to determine progressively increase low voltage fast activity in icEEG (Fig. 5(a) ). But amplitude modulation in the low-power design converts the negative amplitude signal information into positive amplitudes. Therefore, two ADs (only positive comparators) and two FDs are required to determine an upcoming seizure (Fig. 5(b) ). Table II show the comparison between a traditional and low-power detection core. Overall, the new preamplifier (Fig. 5(b) ) has lower power consumption (6.70 W) and improved input-referred noise (6 Vrms) in 17 kHz (2 kHz to 19 kHz) bandwidth. The amplified modulated signal rectified the negative side of signal and passed through two ADs with variable threshold voltages V iHET1 2 . The digital demodulator translated the signal back to baseband and later, the FDs detected seizure frequency by measuring fast activities in time frame T f _i . The T f _i and V iHET1 2 can be tuned to the specific seizure onset frequency of a patient so that no false alarms occur during signal monitoring. 
Controller of Detector
The detection core has several tuneable parameters that are personalized in a specific manner to prevent false seizure detections. The controller of detector (Fig. 4) provides digitally-controlled high precision signal to adjust SD. The controller comprises digital-to-analog converter (DAC D i , buffers (BF D i , and oscillator (OLT 1 . Figure 4 shows that the controller receives 48 bits serial input Data_SD to adjust 6 tuneable parameters (6 × 8 bit) of the detection core.
Electrical Stimulator
The ES has two operating modes: sleep and active mode. During the icEEG monitoring period, the ES stays in sleep mode to improve power management techniques. The detection signal of SD (V SOD interrupts control unit to active mode and generates predefined stimulation waveforms (Fig. 6 ). Figure 4 shows that the entire ES is partitioned into several parts. Control unit of the ES reduces the switching on clock networks and saves power consumption. Optimization of the clock routing power allows to enable those portions of the clock network that are required to feed downstream registers. Furthermore, power is reduced by gating clocks when they are not needed. Moreover, discrete components of the output stage have shutdown mode that reduce further power dissipation. The output stage maintains constant current amplitude for the effective stimulation. A miniaturized ES with wireless system was introduced in our previous work for dysfunctions of the lower urinary tract. 28 In this paper, internal structure of the ES has been modified to adapt in the CLNS and the ranges of stimulation parameters of ES were changed to Table I for the treatment of epilepsy. Further details of the control unit and output stage are described below.
Control Unit
The control unit of the CLNS is based on a commercially available FPGA and the achieved prototype of ES has been made using one of latest FPGA (Ex256). The miniaturized FPGA facilitates low-power multi-function features. Moreover, external controller provides energy and transmits data to the implanted CLNS by means of inductive coupling of spiral antennas. The power recovery module rectifies and filters the carrier signal to provide different regulated power supplies for the implant. The receiver demodulates and sends the Manchester-coded data to the control unit. Details of the power recovery and receiver are described in our previous works. 28 Figure 6 shows the flow chart of the control unit that remains idle unless the data entry or seizure detection signal interrupts it. The control unit is responsible for receiving input parameter values for seizure detections (Data_SD) and electrical stimulations (Data_SD and SWs). The control unit stores the parameters in memory and loads into the detector and stimulator. There are five variable parameters in ES: stimulation duration (T 1 , relax time (T 2 , stimulation frequency (F ES = 1/T 3 , pulse width (T 4 , and stimulation current (I STIM . Figure 7 shows the time process of electrical stimulation with variable parameters. The stimulation duration is defined with the number of stimulation pulses N T and
Output Stage
The output stage retrieves stimulation parameters from the FPGA (stored in Data_ES and SWs), generates biphasic stimulation waveform, and injects to the EZ through the subdural electrodes or to the anterior thalamic nucleus (ATN) by way of depth electrodes. The output stage includes a digital-to-analog converter (DAC S and a current amplifier (CAM) and three sets of synchronous CMOS analog switches to direct the stimuli (Fig. 8(a) ). At first, the V SOD signal interrupts the FPGA to send the amplitude code stored in Data_ES to DAC S . The output voltage of DAC S is converted into a proportional current (I STIM by the CAM and R 1 resistance. The injected currentI STIM is limited by the R 1 . Figure 8(b) shows that the analog switches manipulate constant current (I STIM1 = I STIM and I STIM2 = I STIM /4) and generate biphasic stimulation waveform I ST IM across the two electrodes. Switches SW 1 and SW 2 set the stimulation current direction and Fig. 7 . Timing process of electrical stimulation waveform using variable parameters. SW 3 bypasses high transient current (glitch) of the biphasic stimulation. Moreover, SW 3 switch shunts the CAM output with its negative input before SW 1 and SW 2 activation and confirms the appearance of appropriate stimulation parameter on both electrodes before releasing the SW 3 switch.
EXPERIMENTAL AND CLINICAL RESULTS
The CLNS is assembled into two PCBs (Figs. 9(a and b) ). The ES is designed in two 20 mm diameter circular shape blocks in a PCB. The top part of the ES PCB ( Fig. 9(a) ) contains a spiral antenna, the power and data recovery stages described in Ref. [28] . The bottom part of the ES PCB shows the output stage and its opposite side is the control unit of the ES. On the other hand, the SD is designed in 60 mm diameter PCB. The controller of detection is shown in Figure 9 (b) and the zoom inset shows the detection core, located on the opposite side of Figure 9 (b). The detection core was fabricated in a CMOS 0.18-m process and occupied 2 mm 2 of silicon area. Figure 9 (c) shows photographs of the fabricated chip assembled in a package and zoom inset of the figure shows the fabricated detection core. Details of the measurement and validations are described below.
Circuit Measured Performance
Measurements on each block of the CLNS were done separately. The detection core of the SD was tested on ten samples of the fabricated chip and provided consistent results. Figure 10 shows measured digitally controlled waveforms of T f _i , F S , and V iHET1 2 . Figure 10(a) illustrates the variation of F S from 985 Hz to 5.12 kHz and the corresponding generation of T f _i from 1.6 sec to 16.63 sec. Figure 10 shows that the value of V iHET1 2 can be controlled from 18 mV to 588 mV. On the other hand, in the ES, stimulation current was delivered to a 1 k load and Figure 10 
Method of Case Studies and Validation
This study was conducted at Notre-Dame Hospital, Centre Hospitalier de l'Université de Montréal (CHUM) with approval from the CHUM ethical committee and research ethics committee of Ecole Polytechnique. This study included seven patients (age: 15 to 49) with refractory epilepsy who underwent an intracranial study to better delineate the EZ. Through a craniotomy window, a combination of depth and subdural (strip and/or grid) electrodes were implanted over suspected areas of epileptogenicity. Following the implantation of intracranial electrodes, the patients underwent long-term (∼3 weeks) video-icEEG monitoring (using Stellate's EEG system) in the epilepsy monitoring unit waiting for spontaneous seizures to occur. A post-implantation MRI was used to reconstruct a 3-D representation of electrode positions (using Stellate's gridview software) (Figs. 11(a)-(c) ). Recorded seizures were carefully analyzed to delineate the EZ. For each seizure, onset was marked by an epileptologist (DKN) (yellow marker shown in Fig. 11(d) ). The recordings from the contacts (Fig. 11(c) ) showing earliest ictal changes were fed into the CLNS. Figure 11 (e) shows the validation procedure. The icEEG recordings from the two contacts positioned over the EZ (Fig. 11(c) ) were selected, transferred to the signal conditioner and then to the CLNS for detection and triggering of a predefined electrical stimulation.
Validation of the Closed-Loop Neurostimulator
For each patient, the icEEG recording was fed into the CLNS. Input signals were sampled and modulated at F S , amplified, filtered and analyzed in time-frequency and time-amplitude domain in order to detect seizure. The CLNS was tested on an average of six seizures per patient and results are shown in Table V . The CLNS detected the electroclinical seizures of the seven patients an average of 14.4 s after seizure onset, well before visible clinical manifestation. Figure 12 shows the seizure detection on icEEG recordings (V in from a patient (cases 1 in Table V) and the seizure detection delay T DET = 6.4 s on V SOD , well before clinical manifestation onset. In this study, the CLNS was set to ignore the many BES as the clinician judged them to be too short and frequent, and not always leading to clinical manifestations. In response to the early detection of seizure development V SOD , a burst (T 1 = 1 3 s) of 198.4 Hz bipolar biphasic stimulation was administered and no stimulation period V NS began right after the stimulation period (Fig. 12) . However, the proper stimulation parameters need to be individualized during the presurgical icEEG study for maximum efficacy prior to the implantation of a stimulation device. Power consumption of the CLNS was dominated by the stimulation current and waveforms; however 4 mW power was continuously dissipated by the CLNS in sleep mode. Power dissipation densities ( P of the seizure detector and electrical stimulator were under maximum safety level ( Pmax = 6 mW/cm 2 that may cause enough heat to damage surrounding tissue). 36 Figures 13(a)-(b) illustrate devices operation modes in icEEG recording and corresponding average P .
Performance Analysis of the Proposed CLNS
Detection performance of the proposed detector based on seven patients with refractory epilepsy and all the detection performed before clinical manifestation. This performance was evaluated in terms of power consumption and sensitivity of the detector. This detector has performed better than feature extraction process (FEP), 20 dual-path detector (DPD), 22 event-based seizure detector (ESD), 25 cascaded two-stage seizure detector (CSD), 26 and linear discriminant analysis classifier (LDA).
27 Figure 14 illustrates the comparative analysis and it shows that the power consumption of the proposed detector is lower and sensitivity of the detector is higher than Refs. [20, 22, [25] [26] [27] . Moreover, the proposed detector demonstrates the use of different effective detection parameters for creating several decision boundaries and reduces the number of false detections for the patient's specific seizure onset pattern while enhanced the sensitivity. The detector can categorize different electrographic icEEG patterns (e.g., normal neural activity, low-voltage fast activity, slow spike wave, brief electrical seizure, artifact, and progressive amplitude increase signal) and identify the specific electrographic pattern at the seizure onset without having false detection.
There has been very few electrical stimulator reported for suppressing upcoming seizure. The pilot study 5 11 was done using a large constant current stimulator (S-12; Grass Instruments). Neuropace Inc. (Mountain View, California, US) has a responsive neurostimulator (RNS) system and investigation on the device is evaluated in clinical trials. 6 The detection algorithm of RNS system is based on data reduction (line length function and area under the curve) and feature extraction (half wave analysis). However, the proposed seizure detection is based on noise reduction (modulation), feature extraction (progressively increasing low-voltage fast activity), and data reduction (digitally demodulation). The detection criteria of RNS system are based on high frequency tracking of amplitude variations in icEEG recording, but the proposed algorithm detects progressively increase signal amplitude as well as highfrequency signal in icEEG. Furthermore, Neuropace Inc.
has not yet to publish the hardware description, detection performances and power consumption of their RNS system. A microcontroller based stimulator 7 has been proposed for brain stimulation, but its power consumption is also unknown. Power consumption of the proposed ES is dominated by the stimulation parameters and would vary from patient to patient.
CONCLUSION
In this paper, we present an implantable low-power closedloop neurostimulator for the treatment of epilepsy. This device records icEEG activity, analyzes the signal in timefrequency and time-amplitude domains, and triggers a predefined seizure suppression biphasic electrical stimulation. The proposed CLNS uses low-power management technique. The neural signal amplifier and seizure detector consumes 6.74 W, while power consumption of ES mainly depends on electrical stimulation parameters. The tuneable patient-specific parameters of SD and ES can be adjusted wirelessly. The performance of the CLNS was tested in seven patients with refractory epilepsy and the early detection of seizure was able to trigger subsequent responsive electrical stimulation.
